Top

Onsite Installation and Commissioning Services for EPR System

Active

State & Local

Response Deadline08/27/2026, 06:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Mississippi → UNIVERSITY of SOUTHERN MISSISSIPPIView Agency

NAICS

541714 - Research and Development in Biotechnology (except Nanobiotechnology)View NAICS

Place of Performance

MS, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 10

subcontract

Response DeadlineAug 27

Submission deadline

Response Deadline

08/27/2026, 06:00:00 PM UTCin 17 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyMississippi → UNIVERSITY of SOUTHERN MISSISSIPPI

ContactsNo contacts available

OfficeN/A

Organization / Agency

Mississippi → UNIVERSITY of SOUTHERN MISSISSIPPI

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Onsite installation, configuration, testing, and commissioning of the Xenon EPR software at USM, including system validation and user training.

Similar Contracts

Same NAICS industry code

NAICS: 541714

New

SLED

Extended Warranty Services for SwitchgearThe contract seeks to secure extended warranty services for air-insulated and solid dielectric pad-mounted switches, covering parts, labor, and technical support to ensure continued operational reliability. The scope is focused on maintaining system integrity through comprehensive post-sale service, addressing potential failures and performance issues over an extended period beyond standard manufacturer warranties. This effort is intended to minimize downtime and reduce long-term maintenance costs for critical electrical infrastructure used by the contracting entity. The solicitation is structured as a subcontract under NAICS code 541714, indicating it relates to scientific and technical consulting services. Posted on August 9, 2026, responses are due by September 10, 2026, at 4:30 PM. The contracting agency is Fayetteville State University in North Carolina, with no specific place of performance details provided. The procurement is not subject to a set-aside and is accessible via the official state procurement portal, though no point of contact information is listed within the available data.

Fayetteville State University

POSTED

DEADLINE

Protein ENGineering (PENG)

Solicitation # DARPA-PS-26-129

The Defense Advanced Research Projects Agency (DARPA) is seeking innovative proposals under the Protein ENGineering (PENG) program, solicited through DARPA-PS-26-129, to develop a universal, software-defined platform for precise, programmable editing of endogenous proteins. The goal is to transform proteome engineering from fragmented, target-specific tools into an integrated system capable of directly recognizing, modifying, and rewriting proteins within complex biological environments using modular targeting, generalizable effector chemistries, and multiplexed control systems. Performers are expected to leverage novel splicing, ligation, and co-translational techniques to achieve these modifications in high-fidelity cellular models such as organoids, with progression from foundational validation to robust tissue-level demonstrations. The program is structured over a 42-month total period of performance, divided into an 18-month Base Phase 1, a 6-month Option Phase 1 for capability demonstration, and an 18-month Option Phase 2, spanning fiscal years 2027 through 2030. Performance will occur primarily at the contractor’s facility, with critical milestones requiring on-site demonstrations and DARPA team visits in Arlington, Virginia, where final evaluation and acceptance will take place. Proposals must adhere to strict formatting and documentation standards, including structured cost submissions using designated worksheets with sequentially numbered Reference Document IDs (e.g., EQ001, MAT010) for all equipment and materials over $5,000, supported by vendor quotes and detailed justifications. All cost estimates must comply with Federal Acquisition Regulation cost principles, and no deletion of template columns or cells is permitted. Key personnel—regardless of salary support—must be explicitly listed, and option periods must maintain continuity in document numbering with the base phase. While no explicit contract clauses, evaluation factors, or award methodology are provided, the solicitation emphasizes transparency, traceability, and compliance with Controlled Unclassified Information handling standards. Contractors must be prepared to submit proposals electronically by the October 19, 2026 deadline, with funding ceilings of up to $225,000 for Phase 1, $225,000 for Phase 2, and $160,000 for potential institutional innovation program participation, resulting in a maximum potential contract value of $610,000. No small business set-asides, socioeconomic certifications, or specific invoicing or payment office details are specified,

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA)

Solicitation # W911SR-26-R-HEAL

The Chemical, Biological, Radiological, and Nuclear (CBRN) Medical Countermeasure (MCM) Participant Basic Agreement (PBA) is a continuous, open solicitation designed to establish a dynamic, pre-qualified network of partners to accelerate the development and fielding of next-generation medical defenses against CBRN threats. Operated by the Capability Program Executive for CBRN Defense (CPE CBRND) under the Department of Defense, this agreement functions as an Indefinite-Delivery Indefinite-Quantity (IDIQ)-like vehicle authorized under 10 U.S.C. §§4021, 4022, and 4023, exempting it from the Competition in Contracting Act of 1984. The program seeks innovative, threat-agnostic host-directed therapeutics that enhance physiological resilience by targeting critical systems such as neurological function, respiratory stability, immune response, hematologic and vascular integrity, and cellular stress and repair pathways. Complementary to this, the government also seeks broad-spectrum therapeutic candidates that can directly neutralize CBRN agents, with emphasis on agents possessing environmental stability, non-cold-chain storage capability, and simplified administration routes like oral, intranasal, or autoinjector formats suitable for immediate use in austere, far-forward operational environments. Interested parties, including MCM developers at any stage from Phase I through FDA licensure and supporting organizations such as CROs, CDMOs, and regulatory experts, must submit a white paper of no more than five pages detailing product mechanisms, efficacy data from validated animal models, regulatory status including IND history and clinical trial results, manufacturing capacity and scale-up plans, and company experience. Collaboration is mandatory, with applicants required to state willingness to team or partner within the PBA ecosystem. Participation requires SAM registration, and all award decisions are based on technical merit and strategic alignment with the program’s mission to build a layered, resilient, and sustainable medical defense portfolio, without fixed deadlines or competitive bidding. The agreement supports the development of dual-use medical solutions with potential applications in civilian critical care, emphasizing ruggedized formulations, clear labeling, durable packaging, and long-term stability to ensure readiness in the most challenging operational conditions. Technical and administrative inquiries should be directed to Hunter Robinson or Alexander Mayatte at the Aberdeen Proving Ground, Maryland office.

POSTED

DEADLINE

Universal Cell Culture Platform for Rapid Establishment of Species-Agnostic Cell Lines and Autonomous Culture Operations

Solicitation # DPA26BZ05-DV020

Establishing cell culture systems for non-model vertebrate and invertebrate species remains a major bottleneck in biotechnology, severely limiting progress in gene-drive research, biocontrol development, and species-specific biomanufacturing. Current methods require years of labor-intensive, operator-dependent optimization tailored to each species, with protocols that rarely transfer between labs and lack reproducibility. This contract seeks an integrated platform that eliminates these inefficiencies by enabling rapid, universal derivation of stable cell lines from any species—regardless of taxonomic distance from established models—through species-agnostic biological techniques. These methods must support primary cell isolation, induced pluripotent stem cell reprogramming, and long-term maintenance using broadly applicable media, substrates, and reprogramming strategies that do not rely on species-specific reagents or markers, while also enabling validation of pluripotency, genomic stability, and differentiation potential in the absence of conventional reference tools. To accelerate this process, the platform must pair these biological innovations with fully autonomous, closed-loop automation capable of conducting high-throughput, parallelized experiments with minimal human intervention. The system must independently control environmental parameters at the vessel or well level, perform routine and complex cell culture operations—including feeding, passaging, imaging, and sampling—and use integrated machine-learning-driven analysis to interpret cellular health and morphology, then iteratively propose and execute new experimental conditions. This automation must generate fully digitized, transferable protocols that are reproducible across instruments and locations, compressing years of development into weeks or months. Where applicable, the platform must further support gene-drive and genetic-biocontrol research by providing validated cellular testbeds—including germline or developmentally relevant cell types—that enable in vitro measurement of homing efficiency, off-target activity, stability, and fitness costs, along with molecular containment and safety evaluation strategies. All work under the gene-drive component must remain strictly in vitro, with no environmental release or creation of gene-drive-competent organisms permitted, and must incorporate responsible research practices, biosafety protocols, and institutional oversight. The ultimate goal is a unified system that seamlessly links universal cell culture methods with automated optimization and targeted genetic validation to rapidly enable biological capabilities across the full spectrum of understudied species.

Defense Advanced Research Projects Agency

POSTED

DEADLINE

Evaluation of a Lead NNMT Inhibitor in Humanized M

Solicitation # 75N98026Q00941

The National Institutes of Health, Office of the Director, intends to award a non-competitive, firm-fixed price contract to GemPharmatech LLC for the evaluation of a lead NNMT inhibitor using a humanized nicotinamide N-methyltransferase mouse model, a model uniquely developed and maintained by GemPharmatech under prior NIH funding. This acquisition is conducted under streamlined commercial item procedures and is not expected to exceed the simplified acquisition threshold, with authority derived from FAR 12.603 and 41 U.S.C. 1901, and justified under the sole source exception for unique capabilities, as GemPharmatech is the only entity with the cryopreserved sperm and breeding resources necessary to regenerate the required mouse colony essential for generating scientifically relevant efficacy data due to the inhibitor's species-specific activity. The solicitation number is 75N98026Q00941, issued as a combined synopsis and solicitation without competitive procedures, and responses are due by August 19, 2026. The work falls under NAICS code 541714 for Research and Development in Biotechnology with a small business size standard of 1,000 employees, and this requirement is not set aside for small business. The contract will be managed by the NIH Office of Acquisitions based in Bethesda, Maryland, with the primary point of contact being Johnstona C. Johnston, reachable via email. All provisions and clauses follow those in effect through the Federal Acquisition Circular dated August 4, 2026, and the notice serves as the complete and only solicitation document; no additional written solicitation will be issued. The performance location is not specified beyond the federal agency's administrative details.

National Institutes Of Health Olao

POSTED

DEADLINE

Yeast Two-Hybrid (Y2H) Screening Service

Solicitation # 1232SA26Q1181

The U.S. Department of Agriculture’s Agricultural Research Service is soliciting quotations for Yeast Two-Hybrid (Y2H) Screening Services under solicitation number 1232SA26Q1181, issued as a combined synopsis and solicitation in accordance with FAR Part 12 for commercial items. This acquisition is exclusively reserved for small business concerns, with the North American Industry Classification System code 541714 for Research and Development in Biotechnology and a size standard of 1,000 employees, making it a total small business set-aside. Only responsible small business sources may submit quotations, which will be evaluated without the issuance of a separate written solicitation. The quote submission deadline is August 28, 2026, at 22:00 Eastern Time, with the solicitation publicly posted on August 4, 2026, and responses due to the USDA ARS office located in Beltsville, Maryland. The performance of the Y2H screening services is required to take place in Ithaca, New York, 14853. The primary point of contact for inquiries is Kerrie Hodges, reachable via email at kerrie.hodges@usda.gov. The contract is being procured by the USDA ARS Affiliated Programs and Development office and is intended to support research activities for the Robert W. Holley Center for Agriculture and Health. Interested parties must submit their quotations through the SAM.gov platform using the provided UI link, and all responses must comply with the commercial item procurement procedures outlined in FAR Part 12. No further documentation or separate solicitation documents will be issued.

POSTED

DEADLINE

Solicitation # 1232SA26Q0963

This solicitation, numbered 1232SA26Q0963, is a combined synopsis and request for quotation for genotyping services under FAR Part 12, with no separate written solicitation to follow. It is a total small business set-aside, restricted exclusively to small businesses as defined by the NAICS code 541714 and the 1,000-employee size standard. All responsible small business sources are encouraged to submit quotations, which will be evaluated based on criteria outlined in Attachment 1, which includes the full terms, conditions, and evaluation parameters. The solicitation incorporates provisions and clauses by reference, accessible electronically at www.acquisition.gov. The contract is issued by the USDA ARS AFM APD, with the office located in Beltsville, Maryland, and performance required in Maricopa, Arizona, ZIP 85138. Responses are due by August 12, 2026, at 7:00 p.m. Eastern Time, and the opportunity was posted on August 4, 2026. The primary point of contact for inquiries is Frank Palmer, reachable via email at frank.palmer@usda.gov, and additional details can be viewed on the SAM.gov website at the provided UI link.

POSTED

DEADLINE

Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases

Solicitation # RFA-CK-26-035

The Centers for Disease Control and Prevention, under the Department of Health and Human Services, is soliciting applications through RFA-CK-26-035 to establish a dual-component surveillance network aimed at detecting, preventing, and managing infectious diseases among international travelers. The initiative targets two key environments: clinic-based sentinel sites serving travelers and wastewater-based monitoring at major international transportation hubs, including airports in Addis Ababa, Nairobi, Istanbul, Bangkok, Seoul, and São Paulo. The goal is to enhance early outbreak detection, refine diagnostic and treatment strategies, improve genomic surveillance, and strengthen global health security by generating timely, actionable public health data. Applications may be submitted for Component A, Component B, or both, with the understanding that if a proposal for both components is top-ranked, only Component B will be funded. The program is structured as a cooperative agreement with a five-year performance period beginning September 1, 2027, and an estimated total funding range of $8.75 million to $30 million across both components, with annual funding tiers specified per component. Applicants must adhere to strict submission protocols using the NIH SF-424 (R&R) application package, including a 12-page research strategy per component and a 1-page specific aims section, with no more than 10 PDF attachments allowed in the appendix. Critical requirements include registration in SAM.gov for a Unique Entity ID, eRA Commons registration for all key personnel, IRB approval for human subjects research, OMB-PRA clearance for data collection, and submission of a Bona Fide Agent document, an indirect cost agreement, and a report on proposal overlap if applicable. The CDC will maintain substantial programmatic involvement, requiring prior approval for publications and active collaboration in project execution. Evaluation is based on five scientific merit criteria—Significance, Investigators, Innovation, Approach, and Environment—scored on a 1-to-9 scale, with the final award decision guided by scientific merit, program relevance, portfolio balance, and geographic distribution, not cost. Payment is administered under federal grant rules, with indirect costs capped at 15% using the de minimis rate unless an approved rate is provided. Final reports are due 120 days after project completion, and all data must be shared via the global GLOWACON platform under standardized protocols for wastewater sampling, metagenomic sequencing, and bioinformatics analysis.

Centers For Disease Control And Prevention

POSTED

DEADLINE

Presolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response

Solicitation # 75A50126R00001_RFP_PreSolNotice_NPIVS-2027

The U.S. Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is seeking qualified contractors to support the ongoing Vaccine Medical Countermeasures for Pandemic Influenza Preparedness and Response Program. Contractors must be capable of furnishing all necessary services, personnel, equipment, materials, and U.S.-based facilities to produce vaccines, antigens, and adjuvants for pandemic influenza and other viruses with pandemic potential. To be eligible, offerors must either hold an active U.S. influenza vaccine license from the FDA or have submitted a Biologics License Application for a seasonal or pandemic influenza vaccine. The program demands the generation and submission of comprehensive regulatory data—including analytical, nonclinical, clinical, and chemistry, manufacturing, and controls (CMC) information—to the FDA to enable rapid decision-making and maintain manufacturing readiness during interpandemic periods. The anticipated contract is an indefinite delivery, indefinite quantity (IDIQ) vehicle with a base performance period of 60 months and the potential to extend up to 120 months if all option periods are exercised, combining both cost-reimbursement and firm-fixed-price task orders. Performance is expected to occur primarily within the United States, with the place of performance designated as Washington, D.C., and the contracting office located at 400 7th Street SW. Proposals must be submitted electronically via SAM.gov by the deadline of August 15, 2026, and are subject to evaluation based on mandatory qualification requirements, with full evaluation factors and source selection criteria expected to be detailed in the forthcoming Request for Proposals. The solicitation number is 75A50126R00001, and the NAICS code is 541714 for research and development in biotechnology. The primary point of contact for inquiries is Laura Saddison, BARDA Contracting Officer, reachable at Laura.Saddison@hhs.gov. No set-aside is planned, and full and open competition is anticipated. While packaging, marking, inspection procedures, and specific invoicing methods are not defined in this presolicitation, contractors should prepare to comply with FDA regulatory standards and anticipate the use of federal systems such as WAWF for payment processing. No contracting officer’s representative or technical representative has been designated yet, and all certifications and representations will be required upon formal proposal submission.

Barda - Aspr / Daappo / Barda Dcma

POSTED

DEADLINE

Convergence Special Notice

Solicitation # DARPA-SN-26-108

The Convergence program seeks to revolutionize environmental monitoring for defense operations by integrating synthetic biology and engineering to create advanced microbial biosensors capable of detecting chemical and pharmaceutical hazards in austere environments. Leveraging non-pathogenic microbial consortia built on well-characterized, safe host organisms like E. coli, the initiative focuses on developing modular biological systems that translate environmental inputs into standardized, detectable outputs. The program’s development follows a structured four-tiered approach, progressing from component-level design and integrated payload engineering to full system integration within a microbial chassis, ultimately aiming for a deployable platform ready for U.S. and international regulatory certification. This systematic progression ensures that each layer of functionality is rigorously validated before scaling to operational readiness. To enable safe, responsible, and globally viable deployment, the program includes a dedicated ecosystem of testing and collaboration. Performance and safety validation will first occur within the United States before exploring international adoption, with two specialized working groups guiding the process: one focused on navigating socio-political landscapes and local environmental regulations, and another managing cooperative use cases and deployment protocols with global allies. Administered by DARPA, the solicitation under number DARPA-SN-26-108 invites multidisciplinary teams in synthetic biology, environmental science, and engineering to contribute to this initiative, with responses due by August 6, 2026. The program is headquartered in Arlington, Virginia, and is led by Mark Salvador, with the goal of delivering a scalable, secure, and globally interoperable biosensor platform for the protection of military personnel.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

Multiscale Reasoning For Human Physiology RFI

Solicitation # DARPA-SN-26-100

The Defense Advanced Research Projects Agency’s Biological Technologies Office is seeking input on cutting-edge technologies that enable multiscale reasoning across human physiology through this Request for Information, identified as DARPA-SN-26-100. The focus is on emerging tools including artificial intelligence systems, foundation models, computational frameworks, and datasets capable of integrating biological, physiological, and clinical data across multiple scales—from molecular and cellular levels to organ systems and whole-body responses. The goal is to advance the ability to model, predict, and interpret complex human physiological behavior using AI and data-driven approaches, with interest in non-traditional performers and innovative solutions from industry, academia, government labs, and healthcare organizations. Responses are due by August 10, 2026, and the solicitation falls under NAICS code 541714 for research and development in the physical, engineering, and life sciences. All submissions should be directed to Dr. Roozbeh Jafari, Program Manager at DARPA/BTO, via bioreasoning@darpa.mil. The office is located in Arlington, Virginia, and while no specific place of performance is defined, selected technologies may be developed and evaluated through future DARPA programs. This RFI does not constitute a solicitation for proposals or obligations but aims to inform upcoming funding opportunities in the field of physiological modeling and AI-driven biological insight.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

Trusted Partner Program Coming Soon

Solicitation # W911NF26RA009

The U.S. Army, through the Army Research Office and the Office of Contracting at Research Triangle Park, North Carolina, is issuing a presolicitation for the Trusted Partner Program, a multiple-award IDIQ contract aimed at establishing a cadre of trusted academic partners—including institutions of higher education and their affiliated entities—to conduct rapid, sensitive basic and applied scientific research in support of national defense priorities. The solicitation, numbered W911NF26RA009, targets research in Scaled Directed Energy and Scaled Hypersonics, requiring multidisciplinary expertise across physics, electronics, chemistry, materials science, information sciences, and biology, with an emphasis on integrating these fields to address complex Army needs. The base performance period is five years, beginning September 2026, with an optional five-year extension, bringing the total potential contract value to $400 million, with individual task orders to be issued under cost-plus-fixed-fee or firm-fixed-price arrangements. Offerors must submit proposals in five separate volumes, each as a searchable PDF, along with a supplemental unclassified video pitch between three and seven minutes in length, formatted in MPEG-4 at 1080p resolution. Proposals are due by 4:00 PM Eastern Time on July 15, 2026, and must be emailed to the designated point of contact. Evaluation will be conducted based on five factors, ranked in order of importance: Technical (most important), Management, Past Performance, Small Business, and Cost & Business Structure (least important non-cost factor). No numerical weights are assigned, and the award will be made using a trade-off process emphasizing superior technical merit over price, with the expectation that all non-cost factors combined carry significantly greater weight than cost. The Technical factor includes equally weighted subfactors centered on expertise in six core disciplines and six critical interdisciplinary projects, assessed using adjectival ratings from BLUE (outstanding, low risk) to RED (unacceptable, unawardable). Compliance with regulatory requirements is strict: contractors must maintain active UEI and CAGE codes in SAM, adhere to cybersecurity maturity model certification requirements, and submit all deliverables in accordance with Department of Transportation packaging standards and marking requirements that include contract number, project title, and sensitive data classification. Travel is highly regulated, requiring prior COR approval and adherence to JTR per diem limits; OCONUS travel necessitates SPOT registration and a Letter of Authorization. Organizational conflicts of interest will be rigorously assessed, and all

POSTED

DEADLINE

More opportunities from Mississippi → UNIVERSITY of SOUTHERN MISSISSIPPI

Same awarding agency

NAICS: 541690

New

SLED

Data Science & Domain-Specific AI Training Support

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Custom Software Integration & API Development for TAP Platform

Custom Computer Programming Services

POSTED

DEADLINE

AI/ML Model Maintenance & Edge Deployment Support

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

DEADLINE

Xenon Software Workstation Supply and Configuration

Electronic Computer Manufacturing

POSTED

DEADLINE

Xenon EPR Software License and Upgrade

POSTED

DEADLINE

USM SSP 27_003 Notice of Proposed Sole Source Purchase of TAP Maintenance. http://www.ms.gov/dfa/contract_bid_search/Bid RFx: 3150006965 Comments/objections will be received as required per Section 31-7-13 (C) of the Mississippi Code until 8:00 a.m. (Cen

Solicitation # 9280-27-R-RFIN-00004

The University of Southern Mississippi is proposing a sole source purchase for TAP maintenance services under solicitation number 9280-27-R-RFIN-00004, with a posted date of August 10, 2026, and a response deadline of August 27, 2026. This action is being taken in accordance with Section 31-7-13(C) of the Mississippi Code, which allows for sole source procurement under specific circumstances, and public comments or objections must be submitted by 8:00 a.m. Central Time on the deadline date. The contract is classified as a SLED type solicitation, indicating it is for state, local, or educational government use, and the primary point of contact is Amber Floyd, who can be reached via email at amber.floyd@usm.edu or by phone at 601-266-4855. All performance of the services will occur within the state of Mississippi.

POSTED

DEADLINE

USM SSP 27_005 Notice of Proposed Sole Source Purchase of Xenon Lic & Workstation. http://www.ms.gov/dfa/contract_bid_search/Bid RFx: 3150006967 Comments/objections will be received as required per Section 31-7-13 (C) of the Mississippi Code until 8:00 a

Solicitation # 9280-27-R-RFIN-00006

The University of Southern Mississippi is pursuing a sole-source procurement for the Xenon EPR Software upgrade and associated installation services from Bruker BioSpin Corporation, the original equipment manufacturer, to maintain the functionality and compatibility of its existing Bruker EMXmicro Electron Paramagnetic Resonance Spectrometer. This acquisition, identified by solicitation number 9280-27-R-RFIN-00006 and RFx 3150006967, is justified under Section 31-7-13(C) of the Mississippi Code due to the proprietary nature of the software, which is exclusively available from Bruker and cannot be replicated or substituted by any other vendor. The total estimated contract value is $11,505.10, covering the software license, workstation, installation, system integration, testing, and ongoing technical support. The procurement is non-competitive, with no evaluation factors or competitive scoring process, and no option periods or additional line items are included. The place of performance is Mississippi, specifically at the University of Southern Mississippi, where the equipment is located. Submission of objections or comments is permitted until August 27, 2026, at 8:00 a.m. CST, via email to bids@usm.edu or physical mail to 100 Capitol Street, Jackson, MS 39201, with the subject line required to reference the specific SSP number. The procurement is administered by the University’s Director of Procurement & Contracts, Jacob Cochran, with Amber Floyd serving as the primary point of contact. No formal contract clauses from the Federal Acquisition Regulation are provided, and no packaging, marking, inspection criteria, delivery schedules, FOB terms, or accounting identifiers such as TAS or ACRN are specified in the documentation. The vendor’s Unique Entity Identifier, CAGE code, size status, or socioeconomic certifications are also not included, and no representations or certifications from Bruker BioSpin Corporation have been furnished.

Computer and Computer Peripheral Equipment and Software Merchant Wholesalers

POSTED

DEADLINE

Integration and Field Deployment SupportThe contract involves providing on-site technical support for the integration and field deployment of the University of Southern Mississippi’s mROV system, specifically focusing on the spooling of the umbilical onto the winch, signal testing, and verification of operational readiness. This work requires skilled personnel to ensure the proper handling and deployment of critical underwater deployment equipment in a field environment, with a strong emphasis on system functionality and safety. All tasks must be performed in coordination with USM’s technical team and according to established operational protocols to confirm full system readiness for mission use. The solicitation is classified as a subcontract under NAICS code 811212, with a response deadline extended to August 26, 2026, and was posted on August 9, 2026. The work is to be conducted at a location tied to the University of Southern Mississippi’s Mississippi operations, though specific site details are not provided. The contract is part of a broader effort to support advanced underwater robotic system deployment, and interested parties must submit proposals by the deadline to be considered for award. No set-aside provisions or agency-specific requirements beyond the organization’s affiliation are outlined in the available data.

Computer and Office Machine Repair and Maintenance

POSTED

DEADLINE

Logistics, Import, and Delivery CoordinationFibron BX Limited in the UK is required to manage the complete international logistics chain for an umbilical cable shipment destined for USM in Mississippi, encompassing expert packaging, secure freight forwarding, customs clearance in the United States, and final delivery to the specified location. The scope includes full responsibility for all transportation arrangements, compliance with international shipping regulations, and obtaining adequate insurance coverage to protect the cargo throughout transit. The contract is structured as a subcontract under NAICS code 488510, which classifies it as a support activity for transportation, and is issued by the University of Southern Mississippi through its Mississippi office. Bids must be submitted by August 26, 2026, following the posting of the solicitation on August 9, 2026, with no set-aside provisions indicated, leaving the opportunity open to all qualified international and domestic logistics providers.

Freight Transportation Arrangement

POSTED

DEADLINE

Technical Verification and Compliance TestingThe University of Southern Mississippi is seeking a subcontractor to perform independent technical verification and compliance testing on an umbilical cable prior to or upon delivery. The testing must evaluate critical performance parameters including tensile strength to ensure mechanical durability under operational loads, voltage rating to confirm electrical safety and functionality, optical signal integrity to guarantee reliable data transmission, and winch compatibility to verify seamless integration with deployment and retrieval systems. All tests must adhere to established industry standards and documented performance criteria to validate full operational readiness. The solicitation is open for responses until August 26, 2026, and is classified under NAICS code 541380, indicating it relates to other scientific and technical consulting services. Subcontractors are expected to deliver detailed test reports confirming compliance with all specified requirements.

Testing Laboratories and Services

POSTED

DEADLINE

High-Performance Electro-Optical Umbilical Cable SupplyThe University of Southern Mississippi is seeking a subcontractor to supply a single 5,100-meter Fibron RM0049 armored electro-optical umbilical cable specifically engineered for integration with its micro ROV system. This cable is designed for deepwater oceanographic operations and must be compatible with direct-drive winch systems to ensure reliable deployment and retrieval in demanding underwater environments. The umbilical combines fiber-optic data transmission with electrical power delivery within a robust armored structure to withstand high pressures and harsh marine conditions. The solicitation is open for responses until August 26, 2026, and falls under NAICS code 335921, which covers other electrical equipment and component manufacturing. The contract is categorized as a subcontract, with no set-aside provisions indicated. The place of performance and agency office location details are not specified, but the procurement is managed by the University of Southern Mississippi’s Mississippi office. Interested parties must submit proposals through the designated state portal by the stated deadline to be considered for award.

Fiber Optic Cable Manufacturing

POSTED

DEADLINE

USM SSP 27_004 Notice of Proposed Sole Source Purchase of Umbilical Cable. http://www.ms.gov/dfa/contract_bid_search/Bid RFx: 3150006964 Comments/objections will be received as required per Section 31-7-13 (C) of the Mississippi Code until 8:00 a.m. (Ce

Solicitation # 9280-27-R-RFIN-00003

The University of Southern Mississippi is proposing a sole source purchase of an umbilical cable under solicitation number 9280-27-R-RFIN-00003, with the RFx identifier 3150006964. The notice, posted on August 9, 2026, invites comments or objections until 8:00 a.m. on August 26, 2026, as mandated by Section 31-7-13(C) of the Mississippi Code. This procurement falls under NAICS code 335921, categorizing it within the manufacturing of electrical equipment and components. The contract is classified as a SLED acquisition, meaning it is managed by a state, local, or educational agency, with the executing organization being the University of Southern Mississippi operating under the Mississippi state jurisdiction. The place of performance is designated within the state of Mississippi, though no specific city or zip code is provided. Primary point of contact for inquiries is Amber Floyd, reachable via email at amber.floyd@usm.edu or phone at 601-266-4855, and additional details are accessible through the state’s contract bid search portal.

Fiber Optic Cable Manufacturing

POSTED

1 day ago

DEADLINE

in 16 days

View Details